193 results on '"Dasbach, Erik J."'
Search Results
2. Burden of Aspergillosis-Related Hospitalizations in the United States
3. Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age
4. Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview
5. Antibiotic Therapy for Foot Infections in Diabetics [with Reply]
6. The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan
7. Analysis of Health Economic Data
8. Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions
9. Economic Evaluations of Strategies for Preventing Renal Disease in Non-Insulin Dependent Diabetes Mellitus
10. Economic Evaluations of Strategies for Preventing Renal Disease in Non-Insulin Dependent Diabetes Mellitus
11. Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
12. Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the united states during an influenza pandemic
13. Age-Based Programs for Vaccination against HPV
14. Cost-Effectiveness of Strategies for Detecting Diabetic Retinopathy
15. Reductions in Human Papillomavirus-Disease Resource Use and Costs with Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccination: The FUTURE Study Economic Evaluation
16. A Multi-Type HPV Transmission Model
17. The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
18. Model for assessing human papillomavirus vaccination strategies
19. Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: A transmission dynamic model-based evaluation
20. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: Analytic framework and review of the literature
21. Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus
22. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II)
23. New Directions in Pharmacoeconomic Research: The Next Step
24. The health and Economic burden of genital warts in a set of private health plans in the United States. (Major Article)
25. An Economic Overview of Chronic Obstructive Pulmonary Disease
26. The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss
27. Assessment of the cost–effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model
28. Structural differences among cost–effectiveness models of human papillomavirus vaccines
29. Mathematical Models for Predicting the Epidemiologic and Economic Impact of Vaccination against Human Papillomavirus Infection and Disease
30. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma
31. Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: The RENAAL study economic evaluation
32. The Use of Claims Databases in Pharmacoeconomic Studies
33. Self-rated health and mortality in people with diabetes
34. Economic Evaluations of Strategies for Preventing Renal Disease in Non-Insulin Dependent Diabetes Mellitus
35. The Cost-Effectiveness of Losartan versus Captopril in Patients with Symptomatic Heart Failure
36. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model
37. Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia
38. Model of Complications of NIDDM: I. Model construction and assumptions
39. Cost-effectiveness of Intensive Insulin Therapy in the Diabetes Control and Complications Trial
40. Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women
41. Quality of Life in Patients with NIDDM and Nephropathy at Baseline: The Losartan Renal Protection Study (RENAAL)
42. Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
43. 1097Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
44. Cost-effectiveness of intensive insulin therapy in the diabetes control and complications trial
45. Projecting the Clinical Impact of Therapeutic Regimens Including Boceprevir in Previously Untreated Adult Subjects With Chronic Hepatitis C Genotype 1
46. Projecting the Long-Term Clinical Impact of Boceprevir in Patients With Chronic Hepatitis C Genotype-1 Who Failed Prior Treatment With Peginterferon/Ribavirin
47. Impact of vaccinating boys and men against HPV in the United States
48. The cost effectiveness of a quadrivalent human papillomavirus vaccine (6/11/16/18) in Hungary
49. Economics of stockpiling for an influenza pandemic
50. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.